https://medicine.ouhsc.edu/news Parent Page: News id: -1 Active Page: Newsid:22450

College News

An experimental treatment strategy for metastatic pancreatic cancer may help patients live longer by making tumors more visible to the immune system, according to a study published in Nature Medicine. OU Health Stephenson Cancer Center enrolled patients on the clinical trial, which studied a new drug called quemliclustat.

Read more >

Microplastics – minuscule pieces of plastic broken down from larger plastic waste – are a growing concern for human health, especially for the liver. A study from the University of Oklahoma, published today in Science Advances, demonstrates that a common type of microplastics is particularly harmful to the liver under high-fat dietary conditions.

Read more >

University of Oklahoma researcher Wenjing “Lily” Wu, Ph.D., who studies age-related macular degeneration (AMD), isn’t driven solely by scientific curiosity but also by vision loss that has affected generations of her family.

Read more >
Director will bring landmark research program to Oklahoma to advance the vision for ending diabetes

Building on its two-decade journey from a philanthropic vision to a worldwide research enterprise committed to preventing, treating, and curing diabetes, the University of Oklahoma Health Harold Hamm Diabetes Center has named John P. Kirwan, Ph.D., FACSM, a world-leading translational scientist, as its next director, effective Sept. 1, pending approval from the OU Board of Regents.

Read more >
First4Last